Obalon Therapeutics, Inc. (OBLN)

[r clarke]

Obalon Therapeutics, Inc., a vertically integrated medical device company, focuses on developing and commercializing medical devices to treat obese and overweight people by facilitating weight loss.

It offers the Obalon balloon system designed to provide weight loss in obese patients. Obalon Therapeutics, Inc. was founded in 2008 and is headquartered in Carlsbad, California.

WHAT IS OBALON?

The FIRST and ONLY swallowable, FDA-approved 3-balloon system for weight loss.

The Obalon Balloon System is a swallowable intragastric balloon system indicated for temporary use to facilitate weight loss in adults with obesity (BMI of 30 – 40 kg/m2) who have failed to lose weight through diet and exercise. The System is intended to be used as an adjunct to a moderate intensity diet and behavior modification program.

All balloons must be removed 6 months after the first balloon is placed. The Obalon Balloon System helps facilitate weight loss by taking up space in your stomach so you eat less. During treatment you should receive professional nutrition and exercise support to help you make the lifestyle changes that facilitate weight loss. The Obalon Balloon System supports you to help change your eating habits and keep the weight off for the long-term.

Obalon has launched the first and only FDA-approved swallowable, gas-filled intragastric balloon system for the treatment of obesity. The Obalon management team has over 150 combined years of experience in developing and commercializing novel medical technologies with a track record of financial and clinical excellence. For more information, please visit



http://www.obalon.com/